期刊
BIOCHEMISTRY
卷 49, 期 47, 页码 10039-10041出版社
AMER CHEMICAL SOC
DOI: 10.1021/bi1016233
关键词
-
资金
- Alzheimer's Drug Discovery Foundation (ADDF)
- American Health Assistant Foundation (AHAF)
- Mitchell Center for Neurodegenerative Diseases
Tau aggregation is a pathological hallmark of Alzheimer's disease, Parkinson's disease, and many other neurodegenerative disorders known as tauopathies. Tau aggregates take on many forms, and their formation is a multistage process with intermediate stages. Recently, tau oligomers have emerged as the pathogenic species in tauopathies and a possible mediator of amyloid-beta toxicity in Alzheimer's disease. Here, we use a novel, physiologically relevant method (oligomer cross-seeding) to prepare homogeneous populations of tau oligomers and characterize these oligomers in vitro. We show that both A beta and a-synuclein oligomers induce tau aggregation and the formation of beta-sheet-rich neurotoxic tau oligomers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据